ARCA biopharma Inc.

2.40-0.0201-0.83%Vol 20.26K1Y Perf -20.39%
Aug 11th, 2022 15:52 DELAYED
BID2.36 ASK2.40
Open2.44 Previous Close2.42
Pre-Market- After-Market-
 - -  - -%
Target Price
2.00 
Analyst Rating
— 0.00
Potential %
-16.66 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Price Range Ratio 52W %
47.26 
Earnings Rating
Buy
Market Cap34.58M 
Earnings Date
3rd Aug 2022
Alpha-0.02 Standard Deviation0.37
Beta2.03 

Today's Price Range

2.382.47

52W Range

1.713.17

5 Year PE Ratio Range

-0.9000-1.10

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
1.69%
1 Month
-3.62%
3 Months
4.57%
6 Months
22.44%
1 Year
-20.39%
3 Years
-59.19%
5 Years
65.51%
10 Years
-83.19%

TickerPriceChg.Chg.%
ABIO2.40-0.0201-0.83
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
Earnings HistoryEstimateReportedSurprise %
Q02 2022--0.22-
Q01 2022--0.23-
Q03 2021--0.33-
Q02 2021--0.34-
Q01 2021--0.33-
Q04 2020--0.61-
Q03 2020--0.33-
Q02 2020--0.73-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume20.26K
Shares Outstanding14.41K
Shares Float14.30M
Trades Count142
Dollar Volume49.14K
Avg. Volume40.11K
Avg. Weekly Volume36.36K
Avg. Monthly Volume37.28K
Avg. Quarterly Volume46.69K

ARCA biopharma Inc. (NASDAQ: ABIO) stock closed at 2.3999 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 20.26K shares and market capitalization of 34.58M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 20 people. ARCA biopharma Inc. CEO is Michael R. Bristow.

The one-year performance of ARCA biopharma Inc. stock is -20.39%, while year-to-date (YTD) performance is 11.62%. ABIO stock has a five-year performance of 65.51%. Its 52-week range is between 1.71 and 3.1698, which gives ABIO stock a 52-week price range ratio of 47.26%

ARCA biopharma Inc. currently has a PE ratio of -1.90, a price-to-book (PB) ratio of 0.75, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -31.79%, a ROC of -32.31% and a ROE of -33.57%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from ARCA biopharma Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. ARCA biopharma Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ARCA biopharma Inc. is (0), with a target price of $2, which is -16.66% compared to the current price. The earnings rating for ARCA biopharma Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ARCA biopharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ARCA biopharma Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 12.55, ATR14 : 0.10, CCI20 : 53.49, Chaikin Money Flow : 0.09, MACD : -0.01, Money Flow Index : 52.91, ROC : 0.41, RSI : 38.60, STOCH (14,3) : 59.95, STOCH RSI : 0.82, UO : 54.77, Williams %R : -40.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ARCA biopharma Inc. in the last 12-months were: Christopher D. Ozeroff (Buy at a value of $113 210)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
1 (100.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Moderate Buy
2.00

ARCA biopharma Inc.

CEO: Michael R. Bristow

Telephone: +1 720 940-2200

Address: 11080 CirclePoint Road, Westminster 80020, CO, US

Number of employees: 20

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

64%36%

Bearish Bullish

60%40%


News

Stocktwits